[HTML][HTML] Parkinson's disease: from pathogenesis to pharmacogenomics

R Cacabelos - International journal of molecular sciences, 2017 - mdpi.com
Parkinson's disease (PD) is the second most important age-related neurodegenerative
disorder in developed societies, after Alzheimer's disease, with a prevalence ranging from …

[HTML][HTML] Epigenetics in Alzheimer's disease

X Gao, Q Chen, H Yao, J Tan, Z Liu, Y Zhou… - Frontiers in aging …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disease with unknown pathogenesis and
complex pathological manifestations. At present, a large number of studies on targeted …

[HTML][HTML] Epigenetic alterations in Alzheimer's disease

JV Sanchez-Mut, J Gräff - Frontiers in behavioral neuroscience, 2015 - frontiersin.org
Alzheimer's disease (AD) is the major cause of dementia in Western societies. It progresses
asymptomatically during decades before being belatedly diagnosed when therapeutic …

The role of pharmacogenomics in adverse drug reactions

R Cacabelos, N Cacabelos, JC Carril - Expert Review of Clinical …, 2019 - Taylor & Francis
ABSTRACT Introduction: Adverse drug reactions (ADRs) are a major health concern
worldwide. There are multiple causes of ADRs, some of which are preventable …

[HTML][HTML] Epigenetics of aging and Alzheimer's disease: Implications for pharmacogenomics and drug response

R Cacabelos, C Torrellas - International journal of molecular sciences, 2015 - mdpi.com
Epigenetic variability (DNA methylation/demethylation, histone modifications, microRNA
regulation) is common in physiological and pathological conditions. Epigenetic alterations …

Epigenetic changes and its intervention in age-related neurodegenerative diseases

N Mohd Murshid, F Aminullah Lubis… - Cellular and molecular …, 2022 - Springer
Epigenetic mechanisms involving the modulation of gene activity without modifying the DNA
bases are reported to have lifelong effects on mature neurons in addition to their impact on …

Neuroepigenetics of ageing and neurodegeneration-associated dementia: an updated review

FA Mir, A Amanullah, BP Jain, Z Hyderi… - Ageing Research …, 2023 - Elsevier
Gene expression is tremendously altered in the brain during memory acquisition, recall, and
forgetfulness. However, non-genetic factors, including environmental elements, epigenetic …

[HTML][HTML] DNA methylation in neurodegenerative and cerebrovascular disorders

O Martínez-Iglesias, I Carrera, JC Carril… - International journal of …, 2020 - mdpi.com
DNA methylation is an epigenetic mechanism by which methyl groups are added to DNA,
playing a crucial role in gene expression regulation. The aim of the present study is to …

[HTML][HTML] Sirtuins in Alzheimer's disease: SIRT2-related genophenotypes and implications for pharmacoepigenetics

R Cacabelos, JC Carril, N Cacabelos… - International journal of …, 2019 - mdpi.com
Sirtuins (SIRT1-7) are NAD+-dependent protein deacetylases/ADP ribosyltransferases with
important roles in chromatin silencing, cell cycle regulation, cellular differentiation, cellular …

Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer's disease

Y Li, S Lin, Z Gu, L Chen, B He - Bioorganic & Medicinal Chemistry Letters, 2022 - Elsevier
Alzheimer's disease (AD) as the most prevalent dementia type has become one of the
greatest threats to the health and life of the elder people worldwide. Although there has …